Key result
Second-generation DES are not linked to the enhanced ACh-induced vasoconstriction seen with bare metal stents.
Why the study?
Does 2nd-generation DES prevent coronary endothelial dysfunction compared to bare metal stents in patients with coronary artery disease?
Observational (n=112)
Single-blind
Yes
Does 2nd-generation DES prevent coronary endothelial dysfunction compared to bare metal stents in patients with coronary artery disease?
Second-generation drug-eluting stents are not associated with coronary endothelial dysfunction at 6-8 months, unlike bare metal stents which showed enhanced vasoconstriction.
Answers are grounded in this paper and cite their sources.
Second-generation DES may spare coronary endothelial function unlike BMS; hypothesis-generating and leaves open need for randomized confirmation.
We compared vasomotions of target vessels with stents and non-target vessels without stents. Furthermore, we measured the Rho-kinase activation detected in mononucleocytes from aortic and coronary sinus blood. In the target vessels with a BMS, large late lumen loss and acute coronary syndrome (ACS) at the index percutaneous coronary intervention (PCI) were associated with ACh-induced enhanced coronary vasoconstrictive responses. CONCLUSIONS: -generation DESs were not associated with coronary endothelial dysfunction in target vessels, nor activation of Rho-kinase in the coronary sinus blood 6-8 months after stenting.
No takes yet. Share an insight, caveat, or question.
Akiyama et al. (2021) conducted an observational in Coronary artery disease (n=112). 2nd-generation drug-eluting stent (DES) vs. Bare metal stent (BMS) was evaluated on ACh-induced vasoconstrictive responses of target vessels. Second-generation drug-eluting stents did not enhance ACh-induced vasoconstrictive responses in target vessels compared to non-target vessels, whereas bare metal stents enhanced vasoconstriction.
Synapse has enriched 10 related papers. Consider them for comparative context: